Skip to content

APOTHEEK MONNISSEN: what changed

BE 0893.128.488NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€90,384
2024 · €128,376-€37,992
Equity
€119,689
2024 · €109,305+€10,384
Cash
€150,553
2024 · €164,878-€14,325
Balance sheet total
€593,021
2024 · €601,926-€8,906

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€33,843

    up €33,843 (+75.4%), from €44,904 to €78,747

    of which Trade receivables: +€17,957

  • Tangible fixed assets -€31,732

    down €31,732 (-11.2%), from €284,569 to €252,837

    of which Land and buildings: -€28,718

  • Cash -€14,325

    down €14,325 (-8.7%), from €164,878 to €150,553

    mainly Contributions, distributions and other (-€80,000) and Debts after one year (-€52,667)

Equity and liabilities
  • Debts after one year -€52,667

    down €52,667 (-41.7%), from €126,328 to €73,662

    of which Financial debts: -€52,667

  • Other debts +€22,985

    up €22,985 (+8.2%), from €280,810 to €303,796

  • Trade debts +€12,464

    up €12,464 (+43.6%), from €28,619 to €41,084

  • Reserves +€10,384

    up €10,384 (+11.6%), from €89,305 to €99,689

Income statement
  • Gross operating margin -€37,502

    down €37,502 (-19.8%), from €189,265 to €151,763

  • Taxes -€10,920

    down €10,920 (-72.5%), from €15,067 to €4,147

  • Staff costs +€7,973

    up €7,973 (+4,712%), from €169 to €8,142

  • Financial charges +€4,134

    up €4,134 (+47.2%), from €8,766 to €12,900

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €128,376
Gross operating margin -€37,502
Staff costs -€7,973
Depreciation +€649
Other operating charges +€94
Financial income -€46
Financial charges -€4,134
Taxes +€10,920
Result 2025 €90,384
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€118,037
Investment -€1,540
Financing -€130,822
Cash 2024 €164,878
Net result for the year +€90,384
Depreciation +€33,272
Stocks and contracts -€2,564
Receivables within one year -€33,843
Deferred charges and accrued income -€745
Trade debts +€12,464
Tax, wage and social debts +€526
Other debts +€22,985
Accrued charges and deferred income -€4,444
Investment in fixed assets (net) -€1,540
Debts after one year -€52,667
Current portion of long-term debt +€1,845
Contributions, distributions and other -€80,000
Cash 2025 €150,553
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €601,926 €593,021 -€8,906 -1.5%
Fixed assets 21/28 €284,569 €252,837 -€31,732 -11.2%
Tangible fixed assets 22/27 €284,569 €252,837 -€31,732 -11.2%
Land and buildings 22 €276,905 €248,188 -€28,718 -10.4%
Plant, machinery and equipment 23 €6,725 €4,299 -€2,426 -36.1%
Furniture and vehicles 24 €939 €351 -€588 -62.6%
Current assets 29/58 €317,357 €340,183 +€22,826 +7.2%
Stocks and contracts in progress 3 €106,263 €108,827 +€2,564 +2.4%
Stocks 30/36 €106,263 €108,827 +€2,564 +2.4%
Amounts receivable within one year 40/41 €44,904 €78,747 +€33,843 +75.4%
Trade receivables 40 €44,893 €62,849 +€17,957 +40.0%
Other amounts receivable 41 €11 €15,898 +€15,886 +138,501%
Cash at bank and in hand 54/58 €164,878 €150,553 -€14,325 -8.7%
Deferred charges and accrued income 490/1 €1,312 €2,057 +€745 +56.7%
Total equity and liabilities 10/49 €601,926 €593,021 -€8,906 -1.5%
Equity 10/15 €109,305 €119,689 +€10,384 +9.5%
Contributions 10/11 €20,000 €20,000 = 0.0%
Reserves 13 €89,305 €99,689 +€10,384 +11.6%
Distributable reserves 133 €89,305 €99,689 +€10,384 +11.6%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €492,622 €473,332 -€19,290 -3.9%
Amounts payable after more than one year 17 €126,328 €73,662 -€52,667 -41.7%
Financial debts 170/4 €124,498 €71,832 -€52,667 -42.3%
Other amounts payable 178/9 €1,830 €1,830 = 0.0%
Amounts payable within one year 42/48 €360,804 €398,625 +€37,820 +10.5%
Current portion of amounts payable after more than one year 42 €50,822 €52,667 +€1,845 +3.6%
Trade debts 44 €28,619 €41,084 +€12,464 +43.6%
Suppliers 440/4 €28,619 €41,084 +€12,464 +43.6%
Taxes, remuneration and social security 45 €553 €1,079 +€526 +95.2%
Taxes 450/3 €553 €0 -€553 -100%
Remuneration and social security 454/9 - €1,079 +€1,079
Other amounts payable 47/48 €280,810 €303,796 +€22,985 +8.2%
Accrued charges and deferred income 492/3 €5,489 €1,045 -€4,444 -81.0%
Remuneration, social security and pensions 62 €169 €8,142 +€7,973 +4,712%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €33,921 €33,272 -€649 -1.9%
Other operating charges 640/8 €3,102 €3,008 -€94 -3.0%
Gross operating margin 9900 €189,265 €151,763 -€37,502 -19.8%
Operating profit (loss) 9901 €152,073 €107,341 -€44,732 -29.4%
Financial income 75/76B €136 €90 -€46 -33.8%
Recurring financial income 75 €136 €90 -€46 -33.8%
Financial charges 65/66B €8,766 €12,900 +€4,134 +47.2%
Recurring financial charges 65 €8,766 €12,900 +€4,134 +47.2%
Profit (loss) for the period before taxes 9903 €143,443 €94,531 -€48,912 -34.1%
Income taxes 67/77 €15,067 €4,147 -€10,920 -72.5%
Profit (loss) for the period 9904 €128,376 €90,384 -€37,992 -29.6%
Profit (loss) for the period to be appropriated 9905 €128,376 €90,384 -€37,992 -29.6%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€394,091 to €527,789

Midpoint €449,798 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €119,689
Capitalised earnings €668,493 to €935,890
Indication €394,091 to €527,789

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€119,689
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€119,689

Capitalised earnings

net result for the year (9904)
2025
€90,384
2024
€128,376
2023
€62,008
2022
€93,513
2021
€83,155
excluding non-recurring income and charges
€83,305
Average result
€93,589
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€668,493 / €779,908 / €935,890

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 8 November 2026 via checked.be.